Magnus Life Sciences Private Limited
About Magnus Life Sciences Private Limited
Data last updated:
Magnus Life Sciences Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 October 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24230TG2021PTC156325. Its GSTIN is 36AAPCM1133Q1ZZ (Telangana). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹7 Cr and a paid-up capital of ₹7 Cr. It is led by directors Rahul Reddy Peddi and Joji Reddy Tera.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹21.17 Cr, a growth of 57% compared to the previous year. For the same year it recorded a net profit of ₹2.65 Cr (net margin 12.5%) and EBITDA of ₹5.59 Cr (EBITDA margin 26.4%).
The company has about 28 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹14.19 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Magnus Life Sciences Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No.124 Income Tax Housing Colony, Sri Ramakrishna Puram Sarror Nagar Village, Hyderabad, Telangana, India – 500035
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Magnus Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Magnus Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Magnus Life Sciences Private Limited, buy the company report.
Financials of Magnus Life Sciences Private Limited
FY 2025 filings availableMagnus Life Sciences Private Limited reported revenue of ₹21.17 Cr (up 57% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 57% in the latest year. EBITDA rose 112% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹5.59 Cr | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹2.65 Cr | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 26.4% | |||
| Net Profit Margin | 12.5% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Magnus Life Sciences Private Limited, buy the company report.
Board of directors of Magnus Life Sciences Private Limited
Magnus Life Sciences has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rahul Reddy Peddi Also directs: Kria Ventures Private Limited | Director | 25 Oct 2021 | 5 Years 0 Months | Current |
| Joji Reddy Tera | Director | 25 Oct 2021 | 5 Years 0 Months | Current |
Auditor
Magnus Life Sciences Private Limited is audited by A N RAO & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A N RAO & ASSOCIATES | FY 2023 | 014861S |
Shareholding
The shareholding of Magnus Life Sciences Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Magnus Life Sciences Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 20 Nov 2024 | 101003942 | Others | ₹1.96 Cr | Open | |
| 26 May 2023 | 100749127 | Others | ₹9.4 Lakh | Open | |
| 24 Feb 2023 | 100721369 | Others | ₹8.4 Lakh | Open | |
| 07 Sep 2022 | 100616078 | State Bank of India | ₹12.05 Cr | Open |
To see the full charge records of Magnus Life Sciences Private Limited, buy the company report.
Total charge records: 4 View all charges
Legal cases
No court or tribunal cases involving Magnus Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Magnus Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Magnus Life Sciences has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAPCM1133Q1ZZ | Telangana | Active | 11 Nov 2021 |
| 37AAPCM1133Q1ZX | Andhra Pradesh | Active | 11 Nov 2021 |
To see the full GST registrations and return filing status of Magnus Life Sciences Private Limited, buy the company report.
Recent activity
Magnus Life Sciences Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Joji Reddy Tera was appointed as Director on 25 Oct 2021.
Frequently asked questions
Magnus Life Sciences is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 25 October 2021 (5+ years old) and is registered under CIN U24230TG2021PTC156325.
Magnus Life Sciences has 2 current directors:
- Rahul Reddy Peddi - Director
- Joji Reddy Tera - Director
The latest financial statements of Magnus Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Magnus Life Sciences is 36AAPCM1133Q1ZZ, registered in Telangana. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 37AAPCM1133Q1ZX (Andhra Pradesh).
The CIN (Corporate Identification Number) of Magnus Life Sciences is U24230TG2021PTC156325. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Magnus Life Sciences was incorporated on 25 October 2021, making it 5+ years old. It is registered with the Registrar of Companies, Hyderabad.
Joji Reddy Tera was appointed as Director on 25 Oct 2021. Rahul Reddy Peddi was appointed as Director on 25 Oct 2021.
The registered office of Magnus Life Sciences is at Plot No.124 Income Tax Housing Colony, Sri Ramakrishna Puram Sarror Nagar Village, Hyderabad, Telangana, India – 500035.
Magnus Life Sciences operates in the pharma industry, in the drug formulation and development segment.
Magnus Life Sciences has open charges of ₹14.19 Cr and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
